Abstract
The pharmacokinetics of the new anticonvulsant, methindione, carbon-labeled in the carbonyl and N-methyl groups, was studied in experiments on rats. Methindione is quickly absorbed from the gastro-intestinal tract and passes easily through tissue barriers. The highest concentration of methindione in the brain is observed 15–30 min after administration. The metabolism of methindione and its elimination from the tissues take place rapidly. In most tissues only 6–23% of its maximal concentration still remains after administration of the drug. Metabolites of methindione, labeled in the carbonyl group, are excreted mainly through the kidneys, but metabolites labeled in the N-methyl group are excreted chiefly through the lungs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literature Cited
S. K. Germane, Ya. Ya. Ozols, A. K. Aren, et al., Khim.-Farm. Zh., No. 11, 35 (1970).
S. K. Germane, in: Proceedings of the Third Congress of Pharmacologists of the USSR [in Russian], Kiev (1971), p. 70.
G. Ya. Kivman and É. A. Rudzit, Vopr. Med. Khim., No. 4, 369 (1962).
N. A. Plokhinskii, Biometrics [in Russian], Moscow (1970), p. 258.
L. A. Woodbury and C. A. Swinyard, Am. J. Physiol.,170, 661 (1952).
Rights and permissions
About this article
Cite this article
Gilev, A.P., Koptelova, M.N. & Shafro, É.A. Pharmacolinetics of methindione, a new anticonvulsant. Bull Exp Biol Med 78, 1150–1152 (1974). https://doi.org/10.1007/BF00804622
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00804622